The anti suicidal drugs market is anticipated to grow at a significant CAGR of 4.1% during the forecast period. The market is growing due to the high prevalence of depression that leads to suicide attempts and the introduction of several novel drugs. According to FDA, depression is considered a disabling illness that is expected to lead to suicidal thoughts among people. So, pharmaceuticals companies are launching specific drugs for suicidal impulses and driving the growth of the market. Additionally, the off-label recommendation and prescription of anti-depressant and anti-anxiety drugs are also acting as the factor for the growth of the market. However, the insufficient reach of healthcare facilities and unaffordable medication are the major restraining factor for the global anti suicidal drugs market to grow in certain regions.
Get Free Sample link @ https://www.omrglobal.com/request-sample/anti-suicidal-drugs-market
The COVID-19 had impacted the market positively. According to a study by the National Library of Medicine, COVID-19 was associated with distress, anxiety, fear of contagion, depression, and insomnia. Social isolation, fear of contagion, and the uncertainty of life and economics lead to the development of depression, anxiety, and other psychiatric disorder among the population. So, to reduce stress and anxiety among the population, doctors had prescribed anti suicidal drugs to patients with psychiatric and bipolar disorder which have increased the demand for the anti suicidal drugs market globally during the COVID-19 pandemic.
A full report of Global Anti Suicidal Drugs Market available @ https://www.omrglobal.com/industry-reports/anti-suicidal-drugs-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Anti Suicidal Drug Market by Drug Type
- Anti-Depressant & Anti-Anxiety Drug
- N-Methyl-Aspartate Receptor Antagonists
- Antibiotic Analog
- Anti-Psychotic Drug
- Others
Global Anti Suicidal Drug Market by Distribution Channel
- Online
- Offline s
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- Allergan Inc.
- AstraZeneca
- Eli Lilly and Co.
- Pfizer Inc.
- LUNDBECK A/S
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- NRx Pharmaceuticals, Inc.
- VistaGen Therapeutics
The Report Covers
- Market value data analysis of 2022 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global anti suicidal drugs market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/anti-suicidal-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
